Paul E. Fleming

Person

Wellesley, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted pyrrolopyridines as inhibitors of activin receptor-like...
- Patent number 11,236,086
- Issue date Feb 1, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,774,070
- Issue date Sep 15, 2020
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryls and uses thereof
- Patent number 10,538,533
- Issue date Jan 21, 2020
- Millennium Pharmaceuticals, Inc.
- Indu T. Bharathan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 10,233,186
- Issue date Mar 19, 2019
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful for treating disorders related to RET
- Patent number 10,227,329
- Issue date Mar 12, 2019
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,202,365
- Issue date Feb 12, 2019
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
- Patent number 10,202,389
- Issue date Feb 12, 2019
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 1-amino-2-cyclobutylethylboronic acid
- Patent number 10,035,811
- Issue date Jul 31, 2018
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryls and uses thereof
- Patent number 9,802,960
- Issue date Oct 31, 2017
- Millennium Pharmaceuticals, Inc.
- Indu T. Bharathan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
- Patent number 9,796,725
- Issue date Oct 24, 2017
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 1-amino-2-cyclobutylethylboronic acid
- Patent number 9,771,381
- Issue date Sep 26, 2017
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryls and uses thereof
- Patent number 9,751,854
- Issue date Sep 5, 2017
- Millennium Pharmaceuticals, Inc.
- Indu T. Bharathan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
- Patent number 9,663,525
- Issue date May 30, 2017
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
- Patent number 9,290,500
- Issue date Mar 22, 2016
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 9,035,096
- Issue date May 19, 2015
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 1-amino-2-cyclopropylethylboronic acid
- Patent number 9,023,832
- Issue date May 5, 2015
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 1-amino-2-cyclopropylethylboronic acid
- Patent number 8,703,743
- Issue date Apr 22, 2014
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 1-amino-2-cyclobutylethylboronic acid
- Patent number 8,664,200
- Issue date Mar 4, 2014
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 8,569,543
- Issue date Oct 29, 2013
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 1-amino-2-cyclopropylethylboronic acid
- Patent number 8,513,218
- Issue date Aug 20, 2013
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(amino-substituted)-4-aryl pyrimidines and related compounds usef...
- Patent number 8,268,822
- Issue date Sep 18, 2012
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 8,030,517
- Issue date Oct 4, 2011
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 7,999,109
- Issue date Aug 16, 2011
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-carbolines useful for treating inflammatory disease
- Patent number 7,951,801
- Issue date May 31, 2011
- Millennium Pharmaceuticals, Inc.
- Michael E. Hepperle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 7,820,717
- Issue date Oct 26, 2010
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(amino-substituted)-4-aryl pyrimidines and related compounds usef...
- Patent number 7,732,444
- Issue date Jun 8, 2010
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Beta-carbolines useful for treating inflammatory disease
- Patent number 7,727,985
- Issue date Jun 1, 2010
- Millennium Pharmaceuticals, Inc.
- Michael E. Hepperle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 7,659,272
- Issue date Feb 9, 2010
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 7,282,502
- Issue date Oct 16, 2007
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CCR9 inhibitors and methods of use thereof
- Patent number 7,238,717
- Issue date Jul 3, 2007
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20220315585
- Publication date Oct 6, 2022
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE...
- Publication number 20200331908
- Publication date Oct 22, 2020
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS
- Publication number 20190359591
- Publication date Nov 28, 2019
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYLS AND USES THEREOF
- Publication number 20180118762
- Publication date May 3, 2018
- Millennium Pharmaceuticals, Inc.
- Indu T. Bharathan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET
- Publication number 20180022732
- Publication date Jan 25, 2018
- BLUEPRINT MEDICINES CORPORATION
- JASON D. BRUBAKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS
- Publication number 20180022731
- Publication date Jan 25, 2018
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
- Publication number 20170369499
- Publication date Dec 28, 2017
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID
- Publication number 20170349611
- Publication date Dec 7, 2017
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20170298069
- Publication date Oct 19, 2017
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
- Publication number 20170217968
- Publication date Aug 3, 2017
- Millennium Pharmaceuticals, Inc.
- Roushan AFROZE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYLS AND USES THEREOF
- Publication number 20170073326
- Publication date Mar 16, 2017
- Millennium Pharmaceuticals, Inc.
- Indu T. BHARATHAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
- Publication number 20160244455
- Publication date Aug 25, 2016
- Millennium Pharmaceuticals, Inc.
- Roushan AFROZE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20160068479
- Publication date Mar 10, 2016
- Millennium Pharmeceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYLS AND USES THEREOF
- Publication number 20150225422
- Publication date Aug 13, 2015
- Millennium Pharmaceuticals, Inc.
- Indu T. Bharathan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID
- Publication number 20140194387
- Publication date Jul 10, 2014
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID
- Publication number 20140179631
- Publication date Jun 26, 2014
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20140107160
- Publication date Apr 17, 2014
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
- Publication number 20140088096
- Publication date Mar 27, 2014
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID
- Publication number 20140011998
- Publication date Jan 9, 2014
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME
- Publication number 20130217682
- Publication date Aug 22, 2013
- Millennium Pharmaceuticals, Inc.
- Roushan Afroze
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20110313000
- Publication date Dec 22, 2011
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID
- Publication number 20110245203
- Publication date Oct 6, 2011
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(AMINO-SUBSTITUTED)-4-ARYL PYRIMIDINES AND RELATED COMPOUNDS USEF...
- Publication number 20110071134
- Publication date Mar 24, 2011
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20100324093
- Publication date Dec 23, 2010
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20100280074
- Publication date Nov 4, 2010
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
- Publication number 20100093713
- Publication date Apr 15, 2010
- Millennium Pharmaceuticals, Inc.
- Michael E. Hepperle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20100093802
- Publication date Apr 15, 2010
- Millennnium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Derivatives of 1-amino-2-cyclobutylethylboronic acid
- Publication number 20100081633
- Publication date Apr 1, 2010
- Millennium Pharmaceuticals, Inc.
- Paul E. Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 inhibitors and methods of use thereof
- Publication number 20090054495
- Publication date Feb 26, 2009
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCR9 inhibitors and methods of use thereof
- Publication number 20080103180
- Publication date May 1, 2008
- Millennium Pharmaceuticals, Inc.
- Paul Fleming
- C07 - ORGANIC CHEMISTRY

Paul E. Fleming

Person

Patents Grantslast 30 patents

Substituted pyrrolopyridines as inhibitors of activin receptor-like...

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Heteroaryls and uses thereof

Inhibitors of activin receptor-like kinase

Compounds useful for treating disorders related to RET

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Derivatives of 1-amino-2-cyclobutylethylboronic acid

Heteroaryls and uses thereof

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Derivatives of 1-amino-2-cyclobutylethylboronic acid

Heteroaryls and uses thereof

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

CCR9 inhibitors and methods of use thereof

Derivatives of 1-amino-2-cyclopropylethylboronic acid

Derivatives of 1-amino-2-cyclopropylethylboronic acid

Derivatives of 1-amino-2-cyclobutylethylboronic acid

CCR9 inhibitors and methods of use thereof

Derivatives of 1-amino-2-cyclopropylethylboronic acid

2-(amino-substituted)-4-aryl pyrimidines and related compounds usef...

CCR9 inhibitors and methods of use thereof

CCR9 inhibitors and methods of use thereof

Beta-carbolines useful for treating inflammatory disease

CCR9 inhibitors and methods of use thereof

2-(amino-substituted)-4-aryl pyrimidines and related compounds usef...

Beta-carbolines useful for treating inflammatory disease

CCR9 inhibitors and methods of use thereof

CCR9 inhibitors and methods of use thereof

CCR9 inhibitors and methods of use thereof

Patents Applicationslast 30 patents

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE...

2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS

HETEROARYLS AND USES THEREOF

COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET

2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS

PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME

DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME

HETEROARYLS AND USES THEREOF

PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME

CCR9 INHIBITORS AND METHODS OF USE THEREOF

HETEROARYLS AND USES THEREOF

DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID

DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID

CCR9 INHIBITORS AND METHODS OF USE THEREOF

PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME

DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID

PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME

CCR9 INHIBITORS AND METHODS OF USE THEREOF

DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBORONIC ACID

2-(AMINO-SUBSTITUTED)-4-ARYL PYRIMIDINES AND RELATED COMPOUNDS USEF...

CCR9 INHIBITORS AND METHODS OF USE THEREOF

CCR9 INHIBITORS AND METHODS OF USE THEREOF

BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE

CCR9 INHIBITORS AND METHODS OF USE THEREOF

Derivatives of 1-amino-2-cyclobutylethylboronic acid

CCR9 inhibitors and methods of use thereof

CCR9 inhibitors and methods of use thereof